Wen-bin Zhang
Wuhan, 430060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Protective Effects of Oroxylin A against Doxorubicin-Induced Cardiotoxicity via the Activation of Sirt1 in Mice.
Journal: Oxidative medicine and cellular longevity
Published: November 01, 2020
Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis.
Journal: Oxidative medicine and cellular longevity
Published: August 14, 2020
Protective role of AGK2 on thioacetamide-induced acute liver failure in mice.
Journal: Life sciences
Published: April 16, 2019
Inhibition of HDAC6 attenuates LPS-induced inflammation in macrophages by regulating oxidative stress and suppressing the TLR4-MAPK/NF-κB pathways.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 13, 2019
Quantitative Proteomic Analysis Reveals the Sites Related to Acetylation and Mechanism of ACY-1215 in Acute Liver Failure Mice.
Journal: Frontiers in pharmacology
Published: February 12, 2019
Modulations of Histone Deacetylase 2 Offer a Protective Effect through the Mitochondrial Apoptosis Pathway in Acute Liver Failure.
Journal: Oxidative medicine and cellular longevity
Published: November 15, 2018
Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: January 15, 2018
Histone Deacetylase 2 Inhibitor CAY10683 Alleviates Lipopolysaccharide Induced Neuroinflammation Through Attenuating TLR4/NF-κB Signaling Pathway.
Journal: Neurochemical research
Published: November 29, 2017
The Protective Mechanism of CAY10683 on Intestinal Mucosal Barrier in Acute Liver Failure through LPS/TLR4/MyD88 Pathway.
Journal: Mediators of inflammation
Published: October 30, 2017
Histone deacetylase 6 inhibitor ACY-1215 protects against experimental acute liver failure by regulating the TLR4-MAPK/NF-κB pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 29, 2017
Last Updated: 09/26/2026